Implications and management of pancreatic fistulas following pancreaticoduodenectomy: The Massachusetts General Hospital experience

Archives of Surgery

Volumn 143, Issue 5, 2008, Pages 476-481

  Veillette, Gregory ^a   Dominguez, Ismael ^a   Ferrone, Cristina ^a   Thayer, Sarah P ^a   McGrath, Deborah ^a   Warshaw, Andrew L ^a   Fernández del Castillo, Carlos ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PARENTERAL NUTRITION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

AGED; COHORT STUDIES; DRAINAGE; FEMALE; HOSPITAL MORTALITY; HOSPITALS, GENERAL; HUMANS; LENGTH OF STAY; MALE; MASSACHUSETTS; MIDDLE AGED; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; PARENTERAL NUTRITION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 44149114299     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.5.476     Document Type: Article

References (24)

1. Bassi C, Dervenis C, Butturini G, et al. Post-operative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8-13.
2. Kazanjian KK, Hines OJ, Eibl G, Reber HA. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg. 2005;140(9):849-855.
3. Aranha GV, Aaron JM, Shoup M, Pickleman J. Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2006;140(4):561-569.
4. Choi SH, Moon HJ, Heo JS, Joh JW, Kim YI. Delayed hemorrhage after pancreaticoduodenectomy. J Am Coll Surg. 2004;199(2):186-191.
5. Muscari F, Suc B, Kirzin S, et al; French Associations for Surgical Research. Risk factors for mortality and intra-abdominal complications after pancreaticoduodenectomy: multivariate analysis in 300 patients. Surgery. 2006;139(5):591-598.
6. Munoz-Bongrand N, Sauvanet A, Denys A, Sibert A, Vilgrain V, Belghiti J. Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg. 2004;199(2):198-203.
7. Fernández-del Castillo C, Rattner DW, Warshaw L. Standards for pancreatic resection in the 1990s. Arch Surg. 1995;130(3):295-300.
8. Balcom JH, Rattner DW, Warshaw AL, Chang Y, Fernández-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136(4):391-398.
9. Yeo CJ, Cameron JL, Maher MM, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg. 1995;222(4):580-588.
10. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248-257.
11. Aranha GV, Aaron JM, Shoup M. Critical analysis of pancreaticogastrostomy after pancreaticoduodenectomy. Arch Surg. 2006;141(6):574-580.
12. Pratt WB, Maithel SK, Vanounou T, Huang ZS, Callery MP, Vollmer CM. Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) classification scheme. Ann Surg. 2007;245(3):443-451.
13. Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg. 2004;8(8):951-959.
14. Winter JM, Cameron JL, Campbell KA, et al. Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? results of a prospective randomized trial. J Gastrointest Surg. 2006;10(9):1280-1290.
15. Rodríguez JR, Germes SS, Pandharipande PV, et al. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg. 2006;141(4):361-366.
16. Rodríguez JR, Madanat MG, Healy BC, et al. Distal pancreatectomy with splenic preservation revisited. Surgery. 2007;141(5):619-625.
17. Sarr MG; Pancreatic Surgery Group. The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebocontrolled trial. J Am Coll Surg. 2003;196(4):556-565.
18. Ramos-De la Medina A, Sarr MG. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection. J Hepatobiliary Pancreat Surg. 2006;13(3):190-193.
19. Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232(3):419-429.
20. Lowy AM, Lee JE, Pisters PW, et al. Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg. 1997;226(5):632-641.
21. Barnett SP, Hodul PJ, Creech S, Pickleman J, Aranha GV. Octreotide does not prevent postoperative pancreatic fistula or mortality following pancreaticoduodenectomy. Am Surg. 2004;70(3):222-227.
22. Lillemoe KD, Cameron JL, Kim MP, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? a prospective trial. J Gastrointest Surg. 2004;8(7):766-774.
23. Shrikhande SV, Qureshi SS, Rajneesh N, Shukla PJ. Pancreatic anastomoses after pancreaticoduodenectomy: do we need further studies? World J Surg. 2005; 29(12):1642-1649.
24. Bartoli FG, Arnone GB, Ravera G, et al. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy: review and statistical meta-analysis regarding 15 years of literature. Anticancer Res. 1991;11(5):1831-1848.